2025-05-24 - Analysis Report
Okay, here's the analysis of Albemarle Corp (ALB) based on the data provided, presented in English with a focus on key figures and interpretations:

## Albemarle Corp (ALB) Analysis

**Company Overview:** Albemarle Corp (ALB) is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

**1. Performance vs. S&P 500 (VOO):**

*   **Cumulative Return (ALB):** 1.11
*   **Cumulative Return (VOO):** 79.45
*   **Absolute Divergence:** -78.3
*   **Relative Divergence:** 0.8 (This places ALB's performance near the bottom of its historical range relative to VOO)

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO) over the period examined. The relative divergence of 0.8 indicates that this underperformance is near the worst observed historically.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
| ---------- | ------- | ------ | ------- | ------ | ------ |
| 2015-2017  | 99.0%   | 7.7%   | 70.0%   | 0.0    | 13.7   |
| 2016-2018  | 13.0%   | 58.1%  | -5.0%   | 0.0    | 8.4    |
| 2017-2019  | -45.0%  | 58.1%  | -74.0%  | -0.0   | 8.1    |
| 2018-2020  | 101.0%  | 62.9%  | 75.0%   | 0.7    | 16.6   |
| 2019-2021  | 268.0%  | 62.9%  | 214.0%  | 0.8    | 26.5   |
| 2020-2022  | 239.0%  | 75.8%  | 233.0%  | 1.1    | 24.8   |
| 2021-2023  | -53.0%  | 77.6%  | -69.0%  | 0.6    | 16.6   |
| 2022-2024  | -204.0% | 77.6%  | -221.0% | 0.8    | 10.1   |
| 2023-2025  | -347.0% | 77.6%  | -374.0% | 3.2    | 6.8    |

**Analysis:**

*   **CAGR:** Fluctuating performance over different periods, with significant negative growth in recent years.
*   **MDD:** Maximum Drawdown is consistently high, indicating significant volatility and risk.
*   **Alpha:**  Significant periods of both outperformance and underperformance relative to the market.  Recent years show very negative alpha, indicating substantial underperformance.
*   **Beta:** Beta values are generally low, suggesting a low correlation with the overall market, except the last year where Beta surged to 3.2.
*   **Cap:** Market capitalization has fluctuated.

**2. Recent Price Action:**

*   **Current Price:** 57.61
*   **Previous Close:** 57.94
*   **Change:** -0.57
*   **5-Day Moving Average:** 58.11
*   **20-Day Moving Average:** 58.93
*   **60-Day Moving Average:** 64.62

**Analysis:** The price is below all moving averages, indicating a short-term downtrend. The slight decrease from the previous close with the changes suggests a small negative fluctuation.

**3. Market Risk Indicators:**

*   **Market Risk Indicator (MRI):** 0.3656 (Low Risk)
*   **RSI:** 48.91 (Neutral)
*   **PPO:** 0.25
*   **20-Day Relative Divergence Change:** 0.8 (Positive - indicating a short-term uptick)
*   **Expected Return:** 13173.1% (Projected long-term outperformance vs. S&P 500 if investing now)

**Analysis:**

*   The MRI suggests a Low-Risk environment based on the current reading.
*   RSI is neutral.
*   PPO is slightly positive.
*   The positive change in relative divergence suggests a recent improvement in performance relative to its historical trend (though still lagging the S&P).
*   The extremely high expected return should be viewed with significant skepticism. It is likely a result of the algorithm trying to project a recovery from recent underperformance, and may not be realistic.

**4. Recent News & Significant Events:**

*   **Business Developments/Regulatory Changes/Market Events:** (2025-05-22)
*   **Analyst Discussions (Industry Trends, Global Factors):** (2025-05-20)
*   **Stock Volatility (News, Earnings, Executive Actions):** (2025-05-21)
*   **Risk & Opportunities (Monitor News/Announcements):** (2025-05-24)

**Analysis:** Recent news highlights volatility and the need to monitor company announcements and industry trends. The analyst discussions are likely focused on the factors contributing to the recent underperformance.

**5. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출      |
| ---------- | ------ | --------- |
| 2025-04-30 | 0       | 1.08 B$   |
| 2024-11-06 | -9.45   | 1.35 B$   |
| 2024-07-31 | -1.96   | 1.43 B$   |
| 2024-05-01 | -0.08   | 1.36 B$   |
| 2025-04-30 | -0.08   | 1.36 B$   |

**Analysis:**  Earnings per share (EPS) have been negative in most recent quarters. While revenue has remained relatively stable, the lack of profitability is concerning.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| ------------ | -------- | ------------- |
| 2025-03-31   | $1.08B   | 14.51%      |
| 2024-12-31   | $1.23B   | 11.22%      |
| 2024-09-30   | $1.35B   | -7.68%       |
| 2024-06-30   | $1.43B   | -0.74%       |
| 2024-03-31   | $1.36B   | 2.86%       |

**Capital and Profitability:**

| Quarter      | Equity   | ROE       |
| ------------ | -------- | --------- |
| 2025-03-31   | $10.03B  | 0.41%     |
| 2024-12-31   | $9.96B   | 0.76%     |
| 2024-09-30   | $10.24B  | -10.44%    |
| 2024-06-30   | $11.22B  | -1.68%     |
| 2024-03-31   | $11.53B  | 0.02%     |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been declining recently.  Profit margins have fluctuated and were negative in two of the last five quarters.
*   **Capital and Profitability:**  Equity has decreased overall, and Return on Equity (ROE) has been generally low and negative in some quarters, reflecting poor profitability.

**7. Overall Summary:**

Albemarle Corp (ALB) is currently facing significant challenges.  It has significantly underperformed the S&P 500. Recent earnings have been weak, with negative EPS and fluctuating profit margins. While the MRI indicates a low-risk market environment, the company-specific financials raise concerns.  The extremely high "expected return" should be viewed cautiously. Recent news indicates volatility and scrutiny. Investors should closely monitor upcoming company announcements and industry trends to assess the potential for a turnaround.
